Clinical genetic testing for Kallmann syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 5, 2013, Pages 1860-1862

  Layman, Lawrence C ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR 54; GONADORELIN; GONADORELIN RECEPTOR;

AUTOSOMAL RECESSIVE INHERITANCE; CHROMOSOME TRANSLOCATION; CLEFT LIP; CLEFT PALATE; DELAYED PUBERTY; DNA SEQUENCE; GENE DELETION; GENE MUTATION; GENETIC SCREENING; HEARING IMPAIRMENT; HETEROZYGOSITY; HORMONE SYNTHESIS; HUMAN; HYPODONTIA; KALLMANN SYNDROME; KIDNEY AGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SKELETON MALFORMATION; SYNKINESIS; X CHROMOSOME LINKED DISORDER;

DNA HELICASES; DNA-BINDING PROTEINS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBROBLAST GROWTH FACTOR 8; HUMANS; KALLMANN SYNDROME; MALE; MUTATION; NERVE TISSUE PROTEINS; POLYMORPHISM, GENETIC; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1;

EID: 84877716105     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1624     Document Type: Review

References (19)

1. Franco B, Guioli S, Pragliola A, et al. A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature. 1991;353:529-536.
2. Legouis R, Hardelin JP, Levilliers J, et al. The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell. 1991;67:423-435.
3. Bick D, Franco B, Sherins RS, et al. Intragenic deletion of the KALIG-1 gene in Kallmann's syndrome. N Engl J Med. 1992;326:1752-1755.
4. Hardelin JP, Levilliers J, del Castillo I, et al. X Chromosome-linked Kallmann syndrome: stop mutations validate the candidate gene. Proc Natl Acad Sci USA. 1992;89:8190-8194.
5. de Roux N, Young J, Misrahi M, et al. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N Engl J Med. 1997;337:1597-1602.
6. Layman LC, Cohen DP, Jin M, et al. Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism. Nat Genet. 1998;18:14-15.
7. Layman LC. The genetic basis of female reproductive disorders: etiology and clinical relevance [published online ahead of print March 11, 2013]. Mol Cell Endocrinol. doi: 10.1016/j.mce.2013.02.016.
8. Pitteloud N, Quinton R, Pearce S, et al. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J Clin Invest. 2007;117:457-463.
9. Quaynor SD, Kim HG, Cappello EM, et al. The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome. Fertil Steril. 2011;96:1424-1430 e1426.
10. Newbern K, Natrajan N, Kim HG, et al. Identification of HESX1 mutations in Kallmann syndrome [published online ahead of print March 1, 2013]. Fertil Steril. doi: 10.1016/j.fertnstert.2013.01.149
11. Costa-Barbosa F, Balasubramanian R, Keefe KW, et al. Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotype. J Clin Endocrinol Metab. 2013;98:E943-953
12. Hardelin JP, Levilliers J, Blanchard S, et al. Heterogeneity in the mutations responsible for X chromosome-linked Kallmann syndrome. Hum Mol Genet. 1993;2:373-377.
13. Vissers LE, van Ravenswaaij CM, Admiraal R, et al. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet. 2004;36:955-957.
14. Kim HG, Kurth I, Lan F, et al. Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am J Hum Genet. 2008;83:511-519.
15. Dode C, Levilliers J, Dupont JM, et al. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet. 2003;33:463-465.
16. Abreu AP, Trarbach EB, de Castro M, et al. Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome. J Clin Endocrinol Metab. 2008;93:4113-4118.
17. Dode C, Teixeira L, Levilliers J, et al. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet. 2006;2:e175.
18. Bhagavath B, Xu N, Ozata M, et al. KAL1 mutations are not a common cause of idiopathic hypogonadotrophic hypogonadism in humans. Mol Hum Reprod. 2007;13:165-170.
19. Biesecker LG. Exome sequencing makes medical genomics a reality. Nat Genet. 2010;42:13-14.